Go Pro
NASDAQ:KARD

Kardigan Q2 2026 Earnings Report

$21.78 -0.28 (-1.27%)
As of 04:00 PM Eastern

Kardigan EPS Results

Actual EPS
-$4.61
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Kardigan Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Kardigan Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 11, 2026
Conference Call Time
7:00AM ET

Kardigan Earnings Headlines

How Kardigan spun deal leftovers into a $400M IPO
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. dollar through tariffs, currency pressure, and coordinated policy shifts designed to boost American exports. A weaker dollar means every dollar you've saved buys less - quietly, without a headline or a warning. Smart investors are already repositioning before the slide accelerates.tc pixel
See More Kardigan Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kardigan? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kardigan and other key companies, straight to your email.

About Kardigan

Kardigan (NASDAQ:KARD) Inc. is a clinical-stage precision therapeutics company developing medicines which target the root cause of specific cardiovascular diseases. Kardigan Inc. is based in South San Francisco, California.

View Kardigan Profile